Studies on thiamine metabolism in thiamine-responsive megaloblastic anaemia.
We have investigated thiamine metabolism and transport in the erythrocytes of two patients from unrelated families with thiamine responsive megaloblastic anaemia associated with diabetes mellitus and sensorineural deafness. Both patients had low concentrations of thiamine compounds in plasma and red blood cells. When erythrocytes were incubated with thiazole-[2-14C]-thiamine or [35S]-thiamine in vitro, the concentration of label within the cells was markedly reduced compared with controls. In addition, thiamine pyrophosphokinase activity was deficient in haemolysates prepared from the patients. Some relatives of the patients showed abnormal parameters of thiamine status and transport. In both patients treatment with a lipophilic compound corrected the haematological abnormalities and diabetes and in one patient has so far prevented the progression of deafness. We propose that the disorder is caused by an inherited defect of thiamine transport, possibly related to deficient pyrophosphokinase activity, leading to intracellular depletion of active thiamine metabolite derivatives.
Poggi
V
V
Department of Paediatrics, 2nd Medical School, University of Naples, Italy.
Rindi
G
G
Patrini
C
C
De Vizia
B
B
Longo
G
G
Andria
G
G
D000748:Anemia, Macrocytic / Q000628:therapy*; D000749:Anemia, Megaloblastic / Q000235:genetics / Q000628:therapy*; D002675:Child, Preschool; D003638:Deafness / Q000235:genetics; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D006801:Humans; D008297:Male; D013836:Thiamin Pyrophosphokinase / Q000097:blood; D013831:Thiamine / Q000097:blood / Q000627:therapeutic use*
D013836:Thiamin Pyrophosphokinase; D013831:Thiamine